Effect of Early Assessment Team for Patients Referred to Outpatient Mental Health Care
Launched by ST. OLAVS HOSPITAL · Oct 9, 2021
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new way to support patients who have been referred to outpatient mental health care. The researchers want to see if an Early Assessment Team can help these patients sooner and more effectively than the traditional approach, which often involves long waiting times and specific treatments that may not be suitable for everyone. Many young people face complex challenges that can affect both their mental health and daily life, and the goal of this study is to identify those who might benefit from different types of support rather than just therapy or medication.
To participate in this trial, you need to be someone who has been referred to a general psychiatric outpatient clinic and able to give consent in Norwegian. You should not be someone who needs immediate psychiatric help or is considered too healthy for specialized care. If you join the trial, you'll either receive the standard care or be assessed by the Early Assessment Team, which aims to improve your mental health, quality of life, and daily functioning. This study is important not just for individual patients but also for improving the overall effectiveness of mental health services.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • all patients referred to a general psychiatric outpatient clinic
- • necessary capacity to consent
- • master Norwegian language to such an extent that the patient can understand the written consent
- Exclusion Criteria:
- • patients that an admission team at the outpatient clinic consider obviously must have a TAU for some time
- • patients too healthy to receive specialized mental health care
- • patients in need of acute psychiatric assessment
- • relevant participants who do not respond digitally or who do not confirm consent in writing within given deadlines
About St. Olavs Hospital
St. Olavs Hospital is a leading healthcare institution located in Trondheim, Norway, renowned for its commitment to advancing medical research and improving patient care. As a key clinical trial sponsor, the hospital is dedicated to conducting innovative research across various therapeutic areas, fostering collaboration among multidisciplinary teams of healthcare professionals and researchers. With state-of-the-art facilities and a patient-centric approach, St. Olavs Hospital aims to enhance clinical outcomes and contribute to the global body of medical knowledge through rigorous and ethically conducted clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Trondheim, , Norway
Patients applied
Trial Officials
Jon Helle, MD
Study Chair
Nidelv DPS, Tiller, St.Olavs hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials